Individuals Coming Off Slimming Jabs Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis suggests that patients who come off new GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds far faster than those who end traditional diet and exercise regimens.

Findings released in a prominent medical journal shows that while overweight people frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals purchasing such medications should be informed of the danger of fast rebound weight gain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight in about a year and a half.

Weighing Therapies

The study, which looked at 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with older methods.

Researchers note that people who shed pounds through lifestyle changes alone typically experience a less rapid creep back—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Experts suggest the mechanism of the injections is key to understanding the accelerated weight return.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels several times higher than normal could lead to the system to produce less of its own natural hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making binge eating a significant risk."

An Ongoing Issue?

Medical guidelines advise the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

A number of clinicians argue that, due to the likelihood of weight regain, the therapy should be considered life-long.

This perspective is echoed by pharmaceutical companies, who note that the results "highlight the chronic nature of obesity," akin to managing diseases like high blood pressure.

User Experiences

People who have stopped the medication report a intense return of appetite.

"I experienced something flipping and you're instantly starving," said an individual.

This difficulty is worsened if patients have not adopted sustainable lifestyle or habit modifications during treatment.

Significant Adoption

Figures indicate that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.

• Use is more common among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many access the drugs through private healthcare rather than public health services.

Ultimately, experts emphasize that while these medications are effective agents for shedding pounds, they are not a standalone solution and maintained weight loss relies on integrated lifestyle support.